SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank17
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
0.00
↓ 100% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineCompressed
Average
22.86
Historical baseline
PeriodValueYoY Change
20250.00-100.0%
202423.35+512.4%
2023-5.66-917.4%
20220.69-86.6%
20215.17-34.6%
20207.91-93.9%
2019128.56-